Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 164

1.

Abdominal and Gluteofemoral Size and Risk of Liver Cancer: The Liver Cancer Pooling Project.

Florio AA, Campbell PT, Zhang X, Zeleniuch-Jacquotte A, Wactawski-Wende J, Smith-Warner SA, Sinha R, Simon TG, Sesso HD, Schairer C, Rosenberg L, Rohan TE, Robien K, Renehan AG, Purdue MP, Poynter JN, Palmer JR, Newton CC, Lu Y, Linet MS, Liao LM, Lee IM, Koshiol J, Kitahara CM, Kirsh VA, Hofmann JN, Graubard BI, Giovannucci E, Gaziano JM, Gapstur SM, Freedman ND, Demuth J, Chong DQ, Chan AT, Buring JE, Bradshaw PT, Beane Freeman LE, McGlynn KA, Petrick JL.

Int J Cancer. 2019 Nov 2. doi: 10.1002/ijc.32760. [Epub ahead of print]

PMID:
31677159
2.

Top ten research priorities for detecting cancer early.

Badrick E, Cresswell K, Ellis P; Detecting Cancer Early Priority Setting Partnership steering group (appendix), Renehan AG, Crosbie EJ.

Lancet Public Health. 2019 Nov;4(11):e551. doi: 10.1016/S2468-2667(19)30185-9. Epub 2019 Sep 24. No abstract available.

3.

Interaction between co-morbidities and cancer survival.

Renehan AG, Alam NN, Sperrin M.

Eur J Epidemiol. 2019 Aug 24. doi: 10.1007/s10654-019-00547-w. [Epub ahead of print] No abstract available.

PMID:
31446528
4.

Referral pathways and outcome of patients with colorectal peritoneal metastasis (CRPM).

Larentzakis A, O'Dwyer ST, Becker J, Shuweihdi F, Aziz O, Selvasekar CR, Fulford P, Renehan AG, Wilson M.

Eur J Surg Oncol. 2019 Jul 4. pii: S0748-7983(19)30545-1. doi: 10.1016/j.ejso.2019.07.008. [Epub ahead of print]

PMID:
31433300
5.

Novel phase I trial design to evaluate the addition of cediranib or selumetinib to preoperative chemoradiotherapy for locally advanced rectal cancer: the DREAMtherapy trial.

Marti FEM, Jayson GC, Manoharan P, O'Connor J, Renehan AG, Backen AC, Mistry H, Ortega F, Li K, Simpson KL, Allen J, Connell J, Underhill S, Misra V, Williams KJ, Stratford I, Jackson A, Dive C, Saunders MP.

Eur J Cancer. 2019 Aug;117:48-59. doi: 10.1016/j.ejca.2019.04.029. Epub 2019 Jun 21.

PMID:
31229949
6.

Cancer surveillance, obesity, and potential bias.

Renehan AG, Martin RM, Evans DG.

Lancet Public Health. 2019 May;4(5):e218. doi: 10.1016/S2468-2667(19)30058-1. No abstract available.

7.

Awareness of the link between obesity and cancer in UK school curricula.

Renehan AG, Lloyd K, Renehan I.

Lancet. 2019 Apr 20;393(10181):1591-1592. doi: 10.1016/S0140-6736(18)32765-X. No abstract available.

PMID:
31007192
8.

COSMOS-E: Guidance on conducting systematic reviews and meta-analyses of observational studies of etiology.

Dekkers OM, Vandenbroucke JP, Cevallos M, Renehan AG, Altman DG, Egger M.

PLoS Med. 2019 Feb 21;16(2):e1002742. doi: 10.1371/journal.pmed.1002742. eCollection 2019 Feb.

9.

Early stage anal margin cancer: towards evidence-based management.

Renehan AG, Muirhead R, Berkman L, McParland L, Sebag-Montefiore D; PLATO trial management group.

Colorectal Dis. 2019 Apr;21(4):387-391. doi: 10.1111/codi.14571. No abstract available.

PMID:
30687991
10.

Watch-and-wait strategy in rectal cancer - Authors' reply.

Chadi SA, Beets GL, Perez RO, Renehan AG.

Lancet Gastroenterol Hepatol. 2019 Feb;4(2):97. doi: 10.1016/S2468-1253(18)30418-7. No abstract available.

PMID:
30647019
11.

A core outcome set for clinical trials of chemoradiotherapy interventions for anal cancer (CORMAC): a patient and health-care professional consensus.

Fish R, Sanders C, Adams R, Brewer J, Brookes ST, DeNardo J, Kochhar R, Saunders MP, Sebag-Montefiore D, Williamson PR, Renehan AG.

Lancet Gastroenterol Hepatol. 2018 Dec;3(12):865-873. doi: 10.1016/S2468-1253(18)30264-4. Review.

12.

Is "watch-and-wait" after chemoradiotherapy safe in patients with rectal cancer?

Smith FM, Cresswell K, Myint AS, Renehan AG.

BMJ. 2018 Nov 13;363:k4472. doi: 10.1136/bmj.k4472. Review. No abstract available.

PMID:
30425053
13.

Body mass index trajectories across adulthood and smoking in relation to prostate cancer risks: the NIH-AARP Diet and Health Study.

Kelly SP, Lennon H, Sperrin M, Matthews C, Freedman ND, Albanes D, Leitzmann MF, Renehan AG, Cook MB.

Int J Epidemiol. 2019 Apr 1;48(2):464-473. doi: 10.1093/ije/dyy219.

14.

Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis.

Chadi SA, Malcomson L, Ensor J, Riley RD, Vaccaro CA, Rossi GL, Daniels IR, Smart NJ, Osborne ME, Beets GL, Maas M, Bitterman DS, Du K, Gollins S, Sun Myint A, Smith FM, Saunders MP, Scott N, O'Dwyer ST, de Castro Araujo RO, Valadao M, Lopes A, Hsiao CW, Lai CL, Smith RK, Paulson EC, Appelt A, Jakobsen A, Wexner SD, Habr-Gama A, Sao Julião G, Perez R, Renehan AG.

Lancet Gastroenterol Hepatol. 2018 Dec;3(12):825-836. doi: 10.1016/S2468-1253(18)30301-7. Epub 2018 Oct 12.

15.

Linkage of the UK Clinical Practice Research Datalink with the national cancer registry.

Badrick E, Renehan I, Renehan AG.

Eur J Epidemiol. 2019 Jan;34(1):101-102. doi: 10.1007/s10654-018-0441-5. Epub 2018 Oct 5. No abstract available.

16.

The impact of obesity and bariatric surgery on circulating and tissue biomarkers of endometrial cancer risk.

MacKintosh ML, Derbyshire AE, McVey RJ, Bolton J, Nickkho-Amiry M, Higgins CL, Kamieniorz M, Pemberton PW, Kirmani BH, Ahmed B, Syed AA, Ammori BJ, Renehan AG, Kitchener HC, Crosbie EJ.

Int J Cancer. 2019 Feb 1;144(3):641-650. doi: 10.1002/ijc.31913. Epub 2018 Nov 20.

17.

Framework to construct and interpret latent class trajectory modelling.

Lennon H, Kelly S, Sperrin M, Buchan I, Cross AJ, Leitzmann M, Cook MB, Renehan AG.

BMJ Open. 2018 Jul 7;8(7):e020683. doi: 10.1136/bmjopen-2017-020683.

18.

Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study.

van der Valk MJM, Hilling DE, Bastiaannet E, Meershoek-Klein Kranenbarg E, Beets GL, Figueiredo NL, Habr-Gama A, Perez RO, Renehan AG, van de Velde CJH; IWWD Consortium.

Lancet. 2018 Jun 23;391(10139):2537-2545. doi: 10.1016/S0140-6736(18)31078-X.

PMID:
29976470
19.

Referral and treatment pathways for pseudomyxoma peritonei of appendiceal origin within a national treatment programme.

Fish R, Renehan AG, Punnett G, Aziz O, Fulford P, Selvasekar C, Wilson M, Halstead R, O'Dwyer ST.

Colorectal Dis. 2018 Oct;20(10):888-896. doi: 10.1111/codi.14310. Epub 2018 Jul 26.

PMID:
29920919
20.

Need to Distinguish the Term Sarcopenia From Risk Stratification Derived From Muscle Parameters.

Parkin E, Renehan AG.

J Clin Oncol. 2018 Jul 10;36(20):2128-2129. doi: 10.1200/JCO.2018.78.6988. Epub 2018 May 30. No abstract available.

PMID:
29847291
21.

Effect of More vs Less Frequent Follow-up Testing on Overall and Colorectal Cancer-Specific Mortality in Patients With Stage II or III Colorectal Cancer: The COLOFOL Randomized Clinical Trial.

Wille-Jørgensen P, Syk I, Smedh K, Laurberg S, Nielsen DT, Petersen SH, Renehan AG, Horváth-Puhó E, Påhlman L, Sørensen HT; COLOFOL Study Group.

JAMA. 2018 May 22;319(20):2095-2103. doi: 10.1001/jama.2018.5623.

22.

Change in weight status from childhood to early adulthood and late adulthood risk of colon cancer in men: a population-based cohort study.

Jensen BW, Bjerregaard LG, Ängquist L, Gögenur I, Renehan AG, Osler M, Sørensen TIA, Baker JL.

Int J Obes (Lond). 2018 Oct;42(10):1797-1803. doi: 10.1038/s41366-018-0109-y. Epub 2018 May 22.

PMID:
29789720
23.

Predicting Survival After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Appendix Adenocarcinoma.

Aziz O, Jaradat I, Chakrabarty B, Selvasekar CR, Fulford PE, Saunders MP, Renehan AG, Wilson MS, O'Dwyer ST.

Dis Colon Rectum. 2018 Jul;61(7):795-802. doi: 10.1097/DCR.0000000000001076.

PMID:
29771808
24.

Body-mass index and metastatic melanoma outcomes.

Lennon H, Badrick E, Sperrin M, Renehan AG.

Lancet Oncol. 2018 May;19(5):e225. doi: 10.1016/S1470-2045(18)30277-8. No abstract available.

PMID:
29726384
25.

Prognostic relevance and performance characteristics of serum IGFBP-2 and PAPP-A in women with breast cancer: a long-term Danish cohort study.

Espelund U, Renehan AG, Cold S, Oxvig C, Lancashire L, Su Z, Flyvbjerg A, Frystyk J.

Cancer Med. 2018 Jun;7(6):2391-2404. doi: 10.1002/cam4.1504. Epub 2018 May 3.

26.

Limitations of the National Cancer Data Base to Evaluate Early-Stage Anal Cancer Treatment Outcomes.

Renehan AG, Muirhead R, Sebag-Montefiore D.

JAMA Surg. 2018 Jul 1;153(7):691. doi: 10.1001/jamasurg.2018.0394. No abstract available.

PMID:
29710110
27.

Development of MR quantified pancreatic fat deposition as a cancer risk biomarker.

Coe PO, Williams SR, Morris DM, Parkin E, Harvie M, Renehan AG, O'Reilly DA.

Pancreatology. 2018 Jun;18(4):429-437. doi: 10.1016/j.pan.2018.04.001. Epub 2018 Apr 3.

PMID:
29655566
28.

Systematic review of outcome measures following chemoradiotherapy for the treatment of anal cancer (CORMAC).

Fish R, Sanders C, Ryan N, der Veer SV, Renehan AG, Williamson PR.

Colorectal Dis. 2018 May;20(5):371-382. doi: 10.1111/codi.14103. Epub 2018 Apr 17.

29.

Long-term Quality of Life After Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei: A Prospective Longitudinal Study.

Stearns AT, Malcomson L, Punnett G, Abudeeb H, Aziz O, Selvasekar CR, Fulford PE, Wilson MS, Renehan AG, O'Dwyer ST.

Ann Surg Oncol. 2018 Apr;25(4):965-973. doi: 10.1245/s10434-017-6326-0. Epub 2018 Jan 8.

PMID:
29313146
30.
31.

Anal cancer: different epidemiological and clinical definitions.

Renehan AG, Gilbert D.

Int J Epidemiol. 2017 Dec 1;46(6):2091-2092. doi: 10.1093/ije/dyx198. No abstract available.

PMID:
29025031
32.

Childhood body mass index and height in relation to site-specific risks of colorectal cancers in adult life.

Jensen BW, Gamborg M, Gögenur I, Renehan AG, Sørensen TIA, Baker JL.

Eur J Epidemiol. 2017 Dec;32(12):1097-1106. doi: 10.1007/s10654-017-0289-0. Epub 2017 Aug 12.

PMID:
28803329
33.

Nodal stage migration and prognosis in anal cancer: a systematic review, meta-regression, and simulation study.

Sekhar H, Zwahlen M, Trelle S, Malcomson L, Kochhar R, Saunders MP, Sperrin M, van Herk M, Sebag-Montefiore D, Egger M, Renehan AG.

Lancet Oncol. 2017 Oct;18(10):1348-1359. doi: 10.1016/S1470-2045(17)30456-4. Epub 2017 Aug 9. Review.

34.

Watch-and-wait approach for rectal cancer: concepts of a subject-specific method.

Renehan AG, Malcomson L, Emsley R.

Lancet Gastroenterol Hepatol. 2017 Sep;2(9):627. doi: 10.1016/S2468-1253(17)30218-2. No abstract available.

PMID:
28786383
35.

Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer-Letter.

Alam NN, Badrick E, Sperrin M, Renehan AG.

Cancer Epidemiol Biomarkers Prev. 2017 Jun;26(6):976. doi: 10.1158/1055-9965.EPI-16-0850. Epub 2017 May 15. No abstract available.

36.

Obesity paradox and mortality in adults with and without incident type 2 diabetes: a matched population-level cohort study.

Badrick E, Sperrin M, Buchan IE, Renehan AG.

BMJ Open Diabetes Res Care. 2017 Mar 10;5(1):e000369. doi: 10.1136/bmjdrc-2016-000369. eCollection 2017.

37.

Ki-67 in endometrial cancer: scoring optimization and prognostic relevance for window studies.

Kitson S, Sivalingam VN, Bolton J, McVey R, Nickkho-Amiry M, Powell ME, Leary A, Nijman HW, Nout RA, Bosse T, Renehan AG, Kitchener HC, Edmondson RJ, Crosbie EJ.

Mod Pathol. 2017 Mar;30(3):459-468. doi: 10.1038/modpathol.2016.203. Epub 2016 Dec 2.

38.

Obesity as an Avoidable Cause of Cancer (Attributable Risks).

Renehan AG, Soerjomataram I.

Recent Results Cancer Res. 2016;208:243-256. Review.

PMID:
27909911
39.

Excess Weight as a Risk Factor Common to Many Cancer Sites: Words of Caution when Interpreting Meta-analytic Evidence.

Arnold M, Renehan AG, Colditz GA.

Cancer Epidemiol Biomarkers Prev. 2017 May;26(5):663-665. doi: 10.1158/1055-9965.EPI-16-0940. Epub 2016 Dec 1. No abstract available.

40.

How to Manage the Obese Patient With Cancer.

Renehan AG, Harvie M, Cutress RI, Leitzmann M, Pischon T, Howell S, Howell A.

J Clin Oncol. 2016 Dec 10;34(35):4284-4294. Epub 2016 Nov 7. Review.

PMID:
27903151
41.

Minimally invasive cytoreductive surgery with hyperthermic intraperitoneal chemotherapy - a video vignette.

Bullen TF, Fulford P, Wilson M, Aziz O, Renehan AG, O'Dwyer ST, Selvasekar CR.

Colorectal Dis. 2016 Nov;18(11):1108. doi: 10.1111/codi.13528. No abstract available.

PMID:
27649485
42.

Body mass index relates weight to height differently in women and older adults: serial cross-sectional surveys in England (1992-2011).

Sperrin M, Marshall AD, Higgins V, Renehan AG, Buchan IE.

J Public Health (Oxf). 2016 Sep;38(3):607-613. Epub 2015 Jun 1.

43.

Body Mass Index, Waist Circumference, Diabetes, and Risk of Liver Cancer for U.S. Adults.

Campbell PT, Newton CC, Freedman ND, Koshiol J, Alavanja MC, Beane Freeman LE, Buring JE, Chan AT, Chong DQ, Datta M, Gaudet MM, Gaziano JM, Giovannucci EL, Graubard BI, Hollenbeck AR, King L, Lee IM, Linet MS, Palmer JR, Petrick JL, Poynter JN, Purdue MP, Robien K, Rosenberg L, Sahasrabuddhe VV, Schairer C, Sesso HD, Sigurdson AJ, Stevens VL, Wactawski-Wende J, Zeleniuch-Jacquotte A, Renehan AG, McGlynn KA.

Cancer Res. 2016 Oct 15;76(20):6076-6083.

44.

The Obesity Paradox in Cancer: a Review.

Lennon H, Sperrin M, Badrick E, Renehan AG.

Curr Oncol Rep. 2016 Sep;18(9):56. doi: 10.1007/s11912-016-0539-4. Review.

45.

Watch-and-wait versus surgical resection for patients with rectal cancer - Authors' reply.

Renehan AG, Malcomson L, Emsley R, Scott N, O'Dwyer ST; OnCoRe project investigators.

Lancet Oncol. 2016 Apr;17(4):e134-e135. doi: 10.1016/S1470-2045(16)00166-2. Epub 2016 Mar 29. No abstract available.

PMID:
27300672
46.

Corrigendum to "Techniques and Outcome of Surgery for Locally Advanced and Local Recurrent Rectal Cancer" [Clinical Oncology 28 (2016) 103-115].

Renehan AG.

Clin Oncol (R Coll Radiol). 2016 Aug;28(8):e68. doi: 10.1016/j.clon.2016.05.010. Epub 2016 Jun 9. No abstract available.

PMID:
27291596
47.

Comment on 'New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer'.

Badrick E, Sperrin M, Renehan AG.

Br J Cancer. 2016 May 24;114(11):e11. doi: 10.1038/bjc.2016.99. No abstract available.

48.

The Obesity Paradox and Mortality After Colorectal Cancer: A Causal Conundrum.

Renehan AG, Sperrin M.

JAMA Oncol. 2016 Sep 1;2(9):1127-9. doi: 10.1001/jamaoncol.2016.0868. No abstract available.

PMID:
27195485
49.

The assessment of local response using magnetic resonance imaging at 3- and 6-month post chemoradiotherapy in patients with anal cancer.

Kochhar R, Renehan AG, Mullan D, Chakrabarty B, Saunders MP, Carrington BM.

Eur Radiol. 2017 Feb;27(2):607-617. doi: 10.1007/s00330-016-4337-z. Epub 2016 Apr 18.

50.

Measuring the biological effect of presurgical metformin treatment in endometrial cancer.

Sivalingam VN, Kitson S, McVey R, Roberts C, Pemberton P, Gilmour K, Ali S, Renehan AG, Kitchener HC, Crosbie EJ.

Br J Cancer. 2016 Feb 2;114(3):281-9. doi: 10.1038/bjc.2015.453. Epub 2016 Jan 21.

Supplemental Content

Loading ...
Support Center